Monday, February 09, 2015 7:51:40 PM
You beat me to the punch posting this. Going to share my link to this video on biotech value board. Great stuff. Dying to see if Bill or Legg Mason bought up some of the follow on. Next few weeks could be really nice for both ZIOP and XON.
Looking forward to a string of 5%+ in daily gains for ZIOP. Would make this summer extra special.
Looking forward to a string of 5%+ in daily gains for ZIOP. Would make this summer extra special.
Recent TCRT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:33:30 PM
- Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies • GlobeNewswire Inc. • 05/26/2026 03:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/26/2026 03:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 12:00:43 PM
- Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models • GlobeNewswire Inc. • 05/18/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:29:30 PM
- Valion Bio Appoints Melinda Lackey as General Counsel • PR Newswire (US) • 05/04/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:30:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:18:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:15:27 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 09:14:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 08:32:59 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:33:22 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/05/2026 04:33:21 PM
- Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders • GlobeNewswire Inc. • 03/02/2026 11:30:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 11:29:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2026 09:15:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2026 09:15:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2026 09:15:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 01:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 10:18:31 PM
- Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8) • Edgar (US Regulatory) • 12/11/2025 10:17:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2025 02:32:20 AM
